Skip to main content
N

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,606 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
2025年度股东会决议公告
Regulatory Filings
2026-04-24 Chinese
北京德恒律师事务所关于东北制药集团股份有限公司2025年度股东会的法律意见
Regulatory Filings
2026-04-24 Chinese
诉讼进展公告
Regulatory Filings
2026-04-24 Chinese
2025年度独立董事述职报告(黄永维)
Regulatory Filings
2026-04-02 Chinese
2025年度独立董事述职报告(姚辉-已离任)
Regulatory Filings
2026-04-02 Chinese
关于2025年度会计师事务所履职情况评估报告及董事会审计委员会履行监督职责情况报告
Regulatory Filings
2026-04-02 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.